Buch D L
Hahnemann University School of Medicine, Philadelphia, Pennsylvania.
Am Fam Physician. 1992 Feb;45(2):795-9.
Clozapine is the first truly new antipsychotic drug introduced in the last 40 years. Compared to traditional neuroleptic agents, clozapine appears to have a stronger effect on most schizophrenic symptoms. Thus, it seems to be more effective than other agents in severely ill, treatment-resistant patients. Clozapine rarely causes extrapyramidal symptoms such as pseudoparkinsonism or akathisia. To date, no confirmed cases of tardive dyskinesia have been attributed to the drug. Despite these advantages, the usefulness of clozapine is limited by its potentially life-threatening side effects, which include agranulocytosis and respiratory depression.
氯氮平是过去40年来推出的第一种真正意义上的新型抗精神病药物。与传统抗精神病药物相比,氯氮平似乎对大多数精神分裂症症状有更强的疗效。因此,在重症、难治性患者中,它似乎比其他药物更有效。氯氮平很少引起锥体外系症状,如假性帕金森症或静坐不能。迄今为止,尚无确诊的迟发性运动障碍病例归因于该药物。尽管有这些优点,但氯氮平的应用受到其潜在的危及生命的副作用的限制,这些副作用包括粒细胞缺乏症和呼吸抑制。